10x Genomics Inc (NAS:TXG)
$ 23.95 -0.88 (-3.54%) Market Cap: 2.87 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.13 GF Score: 75/100

10X Genomics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 03:00PM GMT
Release Date Price: $167.5 (+5.10%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

All right. Good morning, everybody. I'm Tycho Peterson from the life science team. Welcome to the JPMorgan Healthcare Conference. It's my pleasure to introduce our next company this morning 10x Genomics. Just a quick reminder, there is a submit question function on the website if people want to have questions asked during the breakup.

And with that, let me turn it over to Serge.

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Let's start with the slides. Thanks, Tycho. Hello, everyone. Let's go to the next slide. Before I move forward with the presentation, I wanted to invite your attention to our safe harbor statement on Slide 2 and to visit our website for additional disclosures regarding any forward-looking statements that are made during the presentation today.

Next slide. Last year, again, the company had very strong performance and execution. Our revenues recovered strongly after dropping precipitously because of the pandemic. Our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot